Support for the latter comes from experimental observations in atherosclerosis models showing that deletion of MCP-1 prevents early atherosclerotic lesion formation, but that it only minimally influences macrophage retention and activation in more advanced lesions [26]. The gene discussed is CCL2; the disease is atherosclerosis.